| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 70, 1114-1118, Copyright © 1990 by Endocrine Society
ARTICLES |
PJ Campbell and JE Gerich
Department of Medicine, Vanderbilt University Medical School, Nashville, Tennessee 37232.
We examined whether obesity must first exceed a critical threshold before it begins to impair insulin action in volunteers with normal glucose tolerance. Forty-nine healthy volunteers, whose ideal body weight ranged from 80-240%, underwent euglycemic clamps during sequential insulin infusions of 0.4, 1.0, and 10 mU/kg.min. Insulin sensitivity was assessed by estimation of the plasma insulin concentration that produced half-maximal glucose disposal (EC50). Glucose disposal during the highest insulin infusion was used as an index of maximal insulin responsiveness. There was a significant correlation between body mass index and insulin sensitivity (EC50) best fitted by a straight line that broke at a body mass index of 26.8 kg/m2 (P less than 0.05). Below this breakpoint (26.8 kg/m2), there was no significant correlation (r = 0.1), whereas above the breakpoint there was a strong positive correlation (r = 0.8; P less than 0.001) between EC50 and body mass index. In contrast, insulin responsiveness was not significantly correlated with body mass index (r = 0.1). We conclude that insulin sensitivity for glucose disposal is impaired in human subjects with normal glucose tolerance who exceed a critical threshold of obesity, which corresponds to an ideal body weight of 120%. This threshold is consistent with the nonlinear (J-shaped) relationship between obesity and its other adverse health consequences, and may have important implications for desirable weight goals.
This article has been cited by other articles:
![]() |
Z. Veleva, A. Tiitinen, S. Vilska, C. Hyden-Granskog, C. Tomas, H. Martikainen, and J. S. Tapanainen High and low BMI increase the risk of miscarriage after IVF/ICSI and FET Hum. Reprod., April 1, 2008; 23(4): 878 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A.R. Doi, M. Al-Zaid, P. A. Towers, C. J. Scott, and K. A.S. Al-Shoumer Irregular cycles and steroid hormones in polycystic ovary syndrome Hum. Reprod., September 1, 2005; 20(9): 2402 - 2408. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E.M. De Block, I. H. De Leeuw, and L. F. Van Gaal Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients Diabetes Care, July 1, 2005; 28(7): 1649 - 1655. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Burke, J. Curran-Celentano, and A. J. Wenzel Diet and Serum Carotenoid Concentrations Affect Macular Pigment Optical Density in Adults 45 Years and Older J. Nutr., May 1, 2005; 135(5): 1208 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Norman, M. Noakes, R. Wu, M. J. Davies, L. Moran, and J. X. Wang Improving reproductive performance in overweight/obese women with effective weight management Hum. Reprod. Update, May 1, 2004; 10(3): 267 - 280. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Morin-Papunen, K. Rautio, A. Ruokonen, P. Hedberg, M. Puukka, and J. S. Tapanainen Metformin Reduces Serum C-Reactive Protein Levels in Women with Polycystic Ovary Syndrome J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4649 - 4654. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Diamanti-Kandarakis, J.-P. Baillargeon, M. J. Iuorno, D. J. Jakubowicz, and J. E. Nestler A Modern Medical Quandary: Polycystic Ovary Syndrome, Insulin Resistance, and Oral Contraceptive Pills J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 1927 - 1932. [Full Text] [PDF] |
||||
![]() |
A. S. Ryan, B. J. Nicklas, and D. M. Berman Hormone Replacement Therapy, Insulin Sensitivity, and Abdominal Obesity in Postmenopausal Women Diabetes Care, January 1, 2002; 25(1): 127 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Franz, J. P. Bantle, C. A. Beebe, J. D. Brunzell, J.-L. Chiasson, A. Garg, L. A. Holzmeister, B. Hoogwerf, E. Mayer-Davis, A. D. Mooradian, et al. Evidence-Based Nutrition Principles and Recommendations for the Treatment and Prevention of Diabetes and Related Complications Diabetes Care, January 1, 2002; 25(1): 148 - 198. [Full Text] [PDF] |
||||
![]() |
A. S. Ryan, B. J. Nicklas, D. M. Berman, and R. E. Ferrell The Insertion/Deletion Polymorphism of the ACE Gene Is Related to Insulin Sensitivity in Overweight Women Diabetes Care, September 1, 2001; 24(9): 1646 - 1652. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. C. Morin-Papunen, I. Vauhkonen, R. M. Koivunen, A. Ruokonen, and J. S. Tapanainen Insulin sensitivity, insulin secretion, and metabolic and hormonal parameters in healthy women and women with polycystic ovarian syndrome Hum. Reprod., June 1, 2000; 15(6): 1266 - 1274. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Clore, J. Li, R. Gill, S. Gupta, R. Spencer, A. Azzam, W. Zuelzer, W. B. Rizzo, and W. G. Blackard Skeletal muscle phosphatidylcholine fatty acids and insulin sensitivity in normal humans Am J Physiol Endocrinol Metab, October 1, 1998; 275(4): E665 - E670. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinozaki, Y. Hattori, M. Suzuki, Y. Hara, A. Kanazawa, H. Takaki, M. Tsushima, and Y. Harano Insulin Resistance as an Independent Risk Factor for Carotid Artery Wall Intima Media Thickening in Vasospastic Angina Arterioscler. Thromb. Vasc. Biol., November 1, 1997; 17(11): 3302 - 3310. [Abstract] [Full Text] |
||||
![]() |
D. J. Jakubowicz and J. E. Nestler 17{alpha}-Hydroxyprogesterone Responses to Leuprolide and Serum Androgens in Obese Women with and without Polycystic Ovary Syndrome after Dietary Weight Loss J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 556 - 560. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Shinozaki, H. Naritomi, T. Shimizu, M. Suzuki, M. Ikebuchi, T. Sawada, and Y. Harano Role of Insulin Resistance Associated With Compensatory Hyperinsulinemia in Ischemic Stroke Stroke, January 1, 1996; 27(1): 37 - 43. [Abstract] [Full Text] |
||||
![]() |
K. Shinozaki, M. Suzuki, M. Ikebuchi, H. Takaki, Y. Hara, M. Tsushima, and Y. Harano Insulin Resistance Associated With Compensatory Hyperinsulinemia as an Independent Risk Factor for Vasospastic Angina Circulation, October 1, 1995; 92(7): 1749 - 1757. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |